Related Experiment Video
Updated: Oct 22, 2025
10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
2.9K
IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis.
Małgorzata Mizerska-Wasiak1, Maria Winiarska2, Karolina Nogal2
1Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Pediatric Reports
|August 27, 2021
Summary
This case study highlights a rare instance of IgA vasculitis with nephritis complicated by both cytomegalovirus (CMV) and tuberculosis infections. Early detection and treatment of infections are crucial for managing this condition in pediatric patients.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Nephrology
Background:
- Immunoglobulin A (IgA) vasculitis is the most prevalent systemic vasculitis in children.
- Nephritis is a common complication, impacting renal function.
- Infections can trigger or worsen IgA vasculitis symptoms.
Observation:
- A pediatric patient with IgA vasculitis and nephritis developed cytomegalovirus (CMV) infection.
- The patient subsequently contracted Mycobacterium tuberculosis infection.
- This represents the first reported case of IgA vasculitis with concurrent CMV and tuberculosis infections.
Findings:
- The co-occurrence of CMV reactivation and tuberculosis in IgA vasculitis is unprecedented in medical literature.
- Infections significantly influence the disease course and severity of IgA vasculitis.
- Antimicrobial therapies are vital for managing proteinuria and preserving renal function.
Implications:
- Immunosuppressive treatments for IgA vasculitis increase the risk of latent infection reactivation.
- Proactive screening for occult infections is essential in patients undergoing immunosuppression.
- Prompt diagnosis and management of infections improve outcomes for pediatric patients with IgA vasculitis and nephritis.
Keywords:
CMVIgA nephropathyIgA vasculitisimmunosuppressive therapynephrotic syndromeproteinuriarenal functiontuberculosisMore Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.3K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.0K
Related Concept Videos
01:26Pulmonary Tuberculosis IV
244
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
244
01:28Pulmonary Tuberculosis V
274
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
274
01:29Pulmonary Tuberculosis I
423
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
423
01:31Pulmonary Tuberculosis III
536
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
536
01:28Pulmonary Tuberculosis II
688
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
688
01:14Myocarditis III: Medical Management
33
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
33